Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000917:Antibody Formation; D002490:Central Nervous System / Q000473:pathology; D002648:Child; D046508:Culture Techniques; D003553:Cystine / Q000378:metabolism*; D005069:Evaluation Studies as Topic; D005243:Feces / Q000382:microbiology; D014644:Genetic Variation; D005827:Genetics, Microbial; D000882:Haplorhini; D006801:Humans; D007668:Kidney; D008251:Macaca; D011051:Poliomyelitis / Q000473:pathology / Q000517:prevention & control; D017955:Poliovirus / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism / Q000472:pathogenicity; D011055:Poliovirus Vaccine, Oral; D013223:Statistics as Topic; D013237:Stereoisomerism; D013997:Time Factors; D014611:Vaccination / Q000009:adverse effects; D014774:Virulence; D014776:Virus Cultivation; D014779:Virus Replication
D011055:Poliovirus Vaccine, Oral; D003553:Cystine